John W. Gofman

6.2k total citations · 4 hit papers
90 papers, 3.3k citations indexed

About

John W. Gofman is a scholar working on Surgery, Cancer Research and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, John W. Gofman has authored 90 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 18 papers in Cancer Research and 14 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in John W. Gofman's work include Lipoproteins and Cardiovascular Health (17 papers), Cancer, Lipids, and Metabolism (17 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers). John W. Gofman is often cited by papers focused on Lipoproteins and Cardiovascular Health (17 papers), Cancer, Lipids, and Metabolism (17 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers). John W. Gofman collaborates with scholars based in United States, Ireland and Germany. John W. Gofman's co-authors include Robert Tandy, Wei Young, Hardin B. Jones, Frank T. Lindgren, Beverly Strisower, Thomas P. Lyon, Harold A. Elliott, Arthur R. Tamplin, Alex V. Nichols and Nathan Malamud and has published in prestigious journals such as Nature, Science and The Lancet.

In The Last Decade

John W. Gofman

84 papers receiving 2.7k citations

Hit Papers

Ischemic Heart Disease, Atherosclerosis, and Longevity 1951 2026 1976 2001 1966 1954 1951 1951 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Ischemic Heart Disease, Atherosclerosis, and Longevity
    1966 476 citations John W. Gofman, Robert Tandy et al. Circulation profile →
  2. Ultracentrifugal Analysis of Serum Lipoproteins
    1954 343 citations John W. Gofman et al. Methods of biochemical analysis profile →
  3. Lipoproteins in atherosclerosis
    1951 211 citations Hardin B. Jones, John W. Gofman et al. profile →
  4. Blood Lipids and Human Atherosclerosis
    1951 169 citations Thomas P. Lyon, John W. Gofman et al. Circulation profile →

Peers

John W. Gofman
N. B. Myant United Kingdom
R. I. Levy United States
A M Gotto United States
Bruce A. Kottke United States
G. Cazzolato Italy
J C Fruchart France
R.M. Krauss United States
E L Bierman United States
John W. Gaubatz United States
Gunnar Fager Sweden
N. B. Myant United Kingdom
John W. Gofman
Citations per year, relative to John W. Gofman John W. Gofman (= 1×) peers N. B. Myant

Countries citing papers authored by John W. Gofman

Since Specialization
Citations

This map shows the geographic impact of John W. Gofman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John W. Gofman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John W. Gofman more than expected).

Fields of papers citing papers by John W. Gofman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John W. Gofman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John W. Gofman. The network helps show where John W. Gofman may publish in the future.

Co-authorship network of co-authors of John W. Gofman

This figure shows the co-authorship network connecting the top 25 collaborators of John W. Gofman. A scholar is included among the top collaborators of John W. Gofman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John W. Gofman. John W. Gofman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gofman, John W., N. K. Freeman, Frank T. Lindgren, et al.. (2007). The serum lipoprotein transport system in health, metabolic disorders, atherosclerosis and coronary heart disease. Journal of clinical lipidology. 1(2). 104–141. 46 indexed citations
2.
Gofman, John W.. (1996). Atherosclerotic Heart Disease and Cancer: Looking for the “Smoking Guns”. The FASEB Journal. 10(5). 661–663. 2 indexed citations
3.
Gofman, John W. & Jack C. Fisher. (1983). Radiation and Human Health. Plastic & Reconstructive Surgery. 72(2). 262–262. 3 indexed citations
4.
Gofman, John W. & Arthur R. Tamplin. (1979). Poisoned power : the case against nuclear power plants before and after Three Mile Island. Medical Entomology and Zoology. 6 indexed citations
5.
Minkler, J.L., et al.. (1971). A long-term effect of radiation on chromosomes of cultured human fibroblasts. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 13(1). 67–75. 10 indexed citations
6.
Merkle, Tanja, et al.. (1965). THE CALCULATION OF TREATMENT SCHEDULES FOR CANCER CHEMOTHERAPY. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 18 indexed citations
7.
Gofman, John W.. (1959). Coronary heart disease. Medical Entomology and Zoology. 19 indexed citations
8.
Gofman, John W.. (1958). Diet in the prevention and treatment of myocardial infarction. The American Journal of Cardiology. 1(2). 271–283. 14 indexed citations
9.
Yasugi, Tadao, et al.. (1958). Relationship of Blood Heparin Levels to Serum Lipoproteins and Cholesterol Levels in Fasting Subjects.. Experimental Biology and Medicine. 98(1). 46–49. 4 indexed citations
10.
Aladjem, Frederick, Miriam Lieberman, & John W. Gofman. (1957). IMMUNOCHEMICAL STUDIES ON HUMAN PLASMA LIPOPROTEINS. The Journal of Experimental Medicine. 105(1). 49–67. 48 indexed citations
11.
Strisower, Beverly, et al.. (1956). LONG-TERM EFFECT OF DESICCATED THYROID SUBSTANCE UPON SERUM LIPOPROTEINS AND SERUM CHOLESTROL.
12.
Gofman, John W.. (1956). SERUM LIPOPROTEINS AND THE EVALUATION OF ATHEROSCLEROSIS. Annals of the New York Academy of Sciences. 64(4). 590–595. 20 indexed citations
13.
Gofman, John W.. (1955). Some concepts of the problem of coronary heart disease in industry.. PubMed. 24(4). 151–6. 3 indexed citations
14.
Gofman, John W., et al.. (1954). Ultracentrifugal Analysis of Serum Lipoproteins. Methods of biochemical analysis. 1. 459–478. 343 indexed citations breakdown →
15.
Elliott, Harold A., et al.. (1954). Ultracentrifugal Studies of High Density Serum Lipoproteins in Clinically Healthy Adults. American Journal of Physiology-Legacy Content. 179(2). 333–337. 82 indexed citations
16.
Kempe, C. Henry, et al.. (1952). The lipoproteins of serum in infancy and childhood. The Journal of Pediatrics. 40(1). 19–23. 2 indexed citations
17.
Engelberg, Hyman, John W. Gofman, & Heather M. Jones. (1952). Serum Lipids and Lipoproteins in Diabetic Glomerulosclerosis: Preliminary Observations of the Effect of Heparin Upon the Disease. Diabetes. 1(6). 425–433. 20 indexed citations
18.
Engelberg, Hyman, John W. Gofman, & Heather M. Jones. (1952). Serum lipids and lipoproteins in diabetic glomerulosclerosis.. PubMed. 1(4). 300–6. 11 indexed citations
19.
Gofman, John W., Frank T. Lindgren, Hardin B. Jones, Thomas P. Lyon, & Beverly Strisower. (1951). Lipoproteins and Atherosclerosis. Journal of Gerontology. 6(2). 105–119. 158 indexed citations
20.
Gofman, John W., et al.. (1951). Macrophage Migration in Experimental Atherosclerosis. Circulation. 4(4). 557–562. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. B. Myant Breakdown of academic impact, for papers by R. I. Levy Breakdown of academic impact, for papers by A M Gotto Breakdown of academic impact, for papers by Bruce A. Kottke Breakdown of academic impact, for papers by G. Cazzolato Breakdown of academic impact, for papers by J C Fruchart Breakdown of academic impact, for papers by R.M. Krauss Breakdown of academic impact, for papers by E L Bierman Breakdown of academic impact, for papers by John W. Gaubatz Breakdown of academic impact, for papers by Gunnar Fager
Rankless by CCL
2026